Wire Stories

Exelixis Announces Partner Takeda and Ono Receive Approval in Japan for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) for the Treatment of Unresectable or Metastatic Renal Cell Carcinoma

– Approval based on the phase 3 CheckMate -9ER pivotal trial, which showed CABOMETYX in…

5 years ago

TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust ("CAPREIT")…

5 years ago

BROOKFIELD, NEWS, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Brookfield Business Partners L.P. (NYSE: BBU) (TSX:…

5 years ago

Los Angeles, CA., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO)…

5 years ago

Net Income of $25.6 million Adjusted EBITDA Increases 10.5% to $75.7 million Same Store Merchandise…

5 years ago

Record Results for the Period This announcement contains inside information for the purposes of Article…

5 years ago

Bonum Bank Plc Stock Exchange Release 16th of August, 2021, at 9.35 AM Bonum Bank…

5 years ago

New York, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video…

5 years ago

SHENZHEN, China, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD”…

5 years ago

GOFORE PLC HALF-YEAR REPORT 13 AUGUST 2021 AT 9:00 EET Gofore Plc’s Half-Year Report 1…

5 years ago